Review article · 2021
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis
JCR Journal of Clinical Rheumatology, 28(2), e407–e414 · Published 26 April 2021 · DOI 10.1097/rhu.0000000000001749
In brief
“The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis” is a 2021 review article by Carlos Alves and 3 co-authors, published in JCR Journal of Clinical Rheumatology. OpenAlex counts 56 citations as of 19 November 2026, which puts it in the top 4% of works published in 2021 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 56
- Most cited in
- 2025 (17)
- Field-weighted impact
- 1.20
- References
- 35
- Authors
- 4
Abstract
BACKGROUND/OBJECTIVE: The Janus kinases (JAKs) are cytoplasmic tyrosine kinases associated with membrane cytokine receptors that mediate signaling of multiple cytokines and growth factors, contributing to the pathogenesis of multiple autoimmune disorders. The JAK inhibitors are a new class of targeted therapies with proven efficacy in treating rheumatoid arthritis but are associated with an increased risk… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Alves, C., Penedones, A., Mendes, D., & Marques, F. B. (2021). The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis. JCR Journal of Clinical Rheumatology, 28(2), e407–e414. https://doi.org/10.1097/rhu.0000000000001749
MLA 9
Alves, Carlos, et al. “The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis.” JCR Journal of Clinical Rheumatology, vol. 28, no. 2, 2021, pp. e407–e414. https://doi.org/10.1097/rhu.0000000000001749.
Chicago
Alves, Carlos, Ana Penedones, Diogo Mendes, and Francisco Batel Marques. 2021. “The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis.” JCR Journal of Clinical Rheumatology 28 (2): e407–e414. https://doi.org/10.1097/rhu.0000000000001749.
Harvard
Alves, C. et al. (2021) ‘The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis’, JCR Journal of Clinical Rheumatology, 28(2), pp. e407–e414. doi:10.1097/rhu.0000000000001749.
IEEE
C. Alves, A. Penedones, D. Mendes, and F. B. Marques, “The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis,” JCR Journal of Clinical Rheumatology, vol. 28, no. 2, pp. e407–e414, 2021, doi: 10.1097/rhu.0000000000001749.
BibTeX
@article{alves2021risk,
title = {{The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis}},
author = {Alves, Carlos and Penedones, Ana and Mendes, Diogo and Marques, Francisco Batel},
journal = {JCR Journal of Clinical Rheumatology},
year = {2021},
volume = {28},
number = {2},
pages = {e407--e414},
doi = {10.1097/rhu.0000000000001749},
url = {https://doi.org/10.1097/rhu.0000000000001749}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 5 | |
| 2022 | 4 | |
| 2023 | 9 | |
| 2024 | 16 | |
| 2025 | 17 | |
| 2026 | 5 |
Its field-weighted citation impact is 1.20: it has been cited 1.20 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- JAK inhibitors
- rheumatoid arthritis
- serious infections
- herpes zoster
- tuberculosis
- drug safety
- filgotinib
- tofacitinib
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Alves, C., Penedones, A., Mendes, D., & Marques, F. B. (2021). The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis. JCR Journal of Clinical Rheumatology, 28(2), e407–e414. https://doi.org/10.1097/rhu.0000000000001749
How many times has this paper been cited?
56 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Carlos Alves, Ana Penedones, Diogo Mendes, Francisco Batel Marques.
What is the DOI of this paper?
10.1097/rhu.0000000000001749, permanently at https://doi.org/10.1097/rhu.0000000000001749. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.